The Adenine Nucleotide Translocator: A New Potential Chemotherapeutic Target
Journal:
Current Drug Targets
Volume:
4
Page:
517-524
Author(s):
Anne-Sophie Belzacq and Catherine Brenner
Tumor Escape from Immune Response: Mechanisms and Targets of Activity
Journal:
Current Drug Targets
Volume:
4
Page:
525-536
Author(s):
Dmitry Gabrilovich and Vladimir Pisarev
The Stress Response: Implications for the Clinical Development of Hsp90 Inhibitors
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
349-358
Author(s):
Luke Whitesell, Rochelle Bagatell and Ryan Falsey
Antibody Penetration Into Living Cells: Pathogenic, Preventive and Immuno-Therapeutic Implications
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1881-1887
Author(s):
Alejandro Ruiz-Arguelles, Liliana Rivadeneyra-Espinoza and Donato Alarcon-Segovia
Gene Therapy of Cancer with Interleukin-12
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1981-1991
Author(s):
Guillermo Mazzolini, Jesus Prieto and Ignacio Melero
Immune Response Manipulation: Recombinant Immunoreceptors Endow T-Cells with Predefined Specificity
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1992-2001
Author(s):
Hinrich Abken, Andreas Hombach and Claudia Heuser
Hypertension and Angiogenesis
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1733-1744
Author(s):
F. N. Kiefer, S. Neysari, R. Humar, W. Li, V. C. Munk and E. J. Battegay
Radiation and Gene Therapy: Rays of Hope for the New Millennium?
Journal:
Current Gene Therapy
Volume:
3
Page:
319-339
Author(s):
M. Boyd, H. S. Spenning and R. J. Mairs
Recurrence in Bladder Cancer: A Molecular Dead End?
Journal:
Current Genomics
Volume:
4
Page:
417-434
Author(s):
John M. S. Bartlett, Joanne Edwards and Ken M. Grigor
Bombesin-like Peptides: Candidates as Diagnostic and Therapeutic Tools
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1013-1022
Author(s):
B. C. Yegen